Pharmacodynamics LAAM acts as a μ-opioid receptor agonist. It also acts as a potent, noncompetitive α3β4 neuronal nicotinic acetylcholine receptor antagonist. Pharmacokinetics LAAM undergoes extensive first-pass metabolism to the active demethylated metabolite nor-LAAM, which is further demethylated to a second active metabolite, dinor-LAAM. These metabolites are more potent than the parent drug.
Levacetylmethadol
Acetylmethadol
Betamethadol
Nalorphine
Alphamethadol
Nalorphine dinicotinate
Desmetramadol
Eptazocine